| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $50K | — |
| SG&A Expense | $844K | -12.1% |
| Operating Income | -$894K | +6.9% |
| Net Income | -$1.5M | +4.2% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $20K | +1689.0% |
| Total Assets | $20K | +1689.0% |
| Current Liabilities | $13.0M | +8.3% |
| Stockholders' Equity | -$13.0M | -8.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$444K | -46.8% |
| Financing Cash Flow | $463K | +65.9% |